Related Experiment Video
Updated: Dec 19, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Outcomes of anatomical vs. functional testing for coronary artery disease : Lessons from the major trials
Júlia Karády1,2, Jana Taron3,4, Andreas Anselm Kammerlander3,5
1Cardiovascular Imaging Research Center, Massachusetts General Hospital-Harvard Medical School, 165 Cambridge St Suite 400, 02114, Boston, MA, USA. jkarady@mgh.harvard.edu.
Insights
Coronary CT angiography, particularly with fractional flow reserve, shows high accuracy for stable coronary artery disease (CAD). This advanced imaging is emerging as a preferred first-line tool over traditional functional testing for diagnosing obstructive CAD.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Testing
Background:
- Estimating pretest probability for obstructive coronary artery disease (CAD) and identifying patients who benefit from revascularization remain challenging.
- Functional testing shows modest agreement with invasive angiography and is less effective in low-prevalence obstructive CAD settings.
- Coronary computed tomography (CT) angiography offers excellent diagnostic accuracy and prognostic value, especially when combined with noninvasive fractional flow reserve (FFR) testing.
Purpose of the Study:
- To provide an overview of the evidence supporting coronary CT angiography in stable CAD evaluation.
- To discuss the clinical implications and limitations of current data on coronary CT angiography.
- To identify areas for future research regarding the role of coronary CT angiography in patient management.
Main Methods:
- Review of existing evidence on coronary CT angiography and fractional flow reserve (FFR) in stable CAD.
- Analysis of landmark trials such as PROMISE and SCOT-HEART.
- Consideration of European Society of Cardiology 2019 Guidelines recommendations.
Main Results:
- Coronary CT angiography, especially with FFR, demonstrates high diagnostic accuracy and prognostic value.
- Evidence challenges the primary role of functional testing in patients without known CAD.
- Landmark trials support the efficient management and improved outcomes with coronary CT angiography.
Conclusions:
- Coronary CT angiography is an emerging first-line tool for evaluating stable chest pain, as recommended by 2019 ESC guidelines.
- Further research is needed to address limitations and remaining questions regarding its optimal use.
- Coronary CT angiography offers a more efficient approach to managing suspected stable CAD compared to traditional methods.
Abstract:
Management of patients presenting with suspected stable coronary artery disease (CAD) are challenging because estimation of pretest probability for obstructive CAD remains difficult. In addition, identification of those who benefit from coronary revascularization remains ineffective regardless of the wide array of noninvasive testing alternatives available. Functional testing, which has long been considered to be the test of choice to risk stratify these patients, shows modest agreement with CAD severity detected by invasive coronary angiography and has been reported to be ineffective in settings of low prevalence of obstructive CAD. A growing body of evidence demonstrates the excellent diagnostic accuracy as well as prognostic value of coronary computed tomography (CT) angiography especially in conjunction with noninvasive fractional flow reserve (FFR) testing, challenging the primary role of functional testing especially in patients without prior or known CAD. Landmark trials, including the Prospective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) and Scottish Computed Tomography of the Heart (SCOT-HEART), have contributed to a better understanding of how coronary CT angiography may play a role in more efficient management and even improved health outcomes. The emerging role of coronary CT has been acknowledged by the 2019 Guidelines of the European Society of Cardiology recommending the use of CT as a first-line tool for the evaluation of patients with stable chest pain with a class I, level of evidence B recommendation. The purpose of this article is to provide an overview on existing evidence, clinical implication, limitations of available data, and remaining questions to be answered by future research.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease V: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

